靶点- |
作用机制- |
|
|
|
非在研适应症- |
最高研发阶段临床1期 |
首次获批国家/地区- |
首次获批日期- |
/ Not yet recruiting临床1期IIT A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending and Multiple Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of Inhaled SUN-001 in Healthy Volunteers
100 项与 Sunterra Bio, Inc. 相关的临床结果
0 项与 Sunterra Bio, Inc. 相关的专利(医药)
100 项与 Sunterra Bio, Inc. 相关的药物交易
100 项与 Sunterra Bio, Inc. 相关的转化医学